TB Archives – Treatment Action Group

Three New Members Elected to TAG’s Board of Directors

July 25, 2024
Dorrit Walsh

Treatment Action Group (TAG) elected three new members to its Board of Directors in May 2024. Board President Ivy Kwan Arce said, "TAG is reinvigorating its Board in alignment with our vision, mission, and values.

2024 Pipeline Report

July 18, 2024
Dorrit Walsh

Pipeline Report provides an overview of research and provides an overview of research and development of innovations for diagnosing, preventing, treating, and curing HIV, hepatitis C virus (HCV), and tuberculosis (TB).

2023 Annual Report

July 17, 2024
Dorrit Walsh

We're pleased to share with you our latest Annual Report, which highlights everything we accomplished in 2023.

Administrative Coordinator

July 2, 2024
Dorrit Walsh

Treatment Action Group (TAG) seeks a highly motivated and organized Administrative Coordinator to support the organization as it continues to grow. This position reports to TAG’s Director of Operations and Human Resources. This is a full-time, salaried position.

Call For New Global TB CAB Members

June 26, 2024
Dorrit Walsh

On behalf of the Global Tuberculosis Community Advisory Board (TB CAB), we're excited to announce a call for new member applications.

TAG Calls on Danaher to Drop the Prices of GeneXpert Tests and Make the Cost Audit Public

June 26, 2024
Dorrit Walsh

Treatment Action Group (TAG) calls on Danaher to lower the price of GeneXpert tests for tuberculosis (TB) and other diseases to $5 each in accordance with publicly available evidence of the cost of manufacturing and to commit to public transparency of the cost audit of Xpert MTB/RIF Ultra.

An Open Letter to Médecins Sans Frontières — Urgent Call to Reverse the Devastating Decision to Shutter the MSF Access Campaign

June 20, 2024
Dorrit Walsh

TAG's emergency plea to our allies at MSF to preserve its life-saving and world-changing MSF Access Campaign (Campaign for Access to Essential Medicines) — we need them now more than ever!

Comments Delivered at the WHO Director-General’s TB Vaccine Accelerator Council

May 30, 2024
Dorrit Walsh

These are the remarks delivered by Mike Frick, TAG’s TB co-director, who was speaking as a civil society representative, at the 2nd meeting of the WHO Director-General’s TB Vaccine Accelerator Council in Geneva Switzerland.

TAG Comments at UN High-Level Meeting on Antimicrobial Resistance Hearing

May 17, 2024
Dorrit Walsh

TAG delivered an intervention at the UN High-Level Meeting on Antimicrobial Resistance (AMR) Multistakeholder Hearing, calling on member states to incorporate drug-resistant TB (DR-TB) in the political declaration as a key component of AMR response.

TB Diagnostics Pipeline: New Tools & Opportunities to Improve Access to Testing

May 15, 2024
Dorrit Walsh

On May 15, 2024, TAG hosted this webinar on the TB Diagnostics Pipeline: New Tools & Opportunities to Improve Access to Testing.